FORUS Therapeutics is thrilled to welcome Girish Nagaonkar as Therapeutic Area Manager, British Columbia. Girish brings extensive experience in the biopharmaceutical industry, with a strong background in specialty care and healthcare professional engagement. Most...
FORUS Therapeutics is thrilled to welcome Anick Guy as Therapeutic Area Manager, Quebec. Anick brings more than 20 years of pharmaceutical experience, with a strong background in hematology-oncology and specialty care. Most recently, she served as Senior Key Account...
FORUS Therapeutics is thrilled to announce Weihao Tang as Senior Product Manager. Weihao brings more than 10 years of experience across the pharmaceutical and clinical diagnostics industries, combining a strong scientific foundation with broad commercial expertise....
FORUS Therapeutics is thrilled to announce Marie-Eve Caron as Associate Director, Sales. Marie-Eve brings more than 20 years of pharmaceutical experience, including over 13 years in specialty care across immunology and hematology/oncology. Throughout her career, she...
(OAKVILLE, Ontario) July 6, 2026 – FORUS Therapeutics Inc (“FORUS”), a wholly owned subsidiary of PharmaEssentia Corp, is pleased to announce that it has received a Notice of Compliance (NOC) authorizing BESREMI® (ropeginterferon alfa-2b) for the treatment of adults...
(OAKVILLE, Ontario) June 11, 2026 – FORUS Therapeutics Inc (“FORUS”) is pleased to announce that it has been acquired by PharmaEssentia Corporation, a global biopharmaceutical company focused on developing innovative therapies for hematology, oncology, and...
Recent Comments